JP2022544227A5 - - Google Patents
Info
- Publication number
- JP2022544227A5 JP2022544227A5 JP2022508480A JP2022508480A JP2022544227A5 JP 2022544227 A5 JP2022544227 A5 JP 2022544227A5 JP 2022508480 A JP2022508480 A JP 2022508480A JP 2022508480 A JP2022508480 A JP 2022508480A JP 2022544227 A5 JP2022544227 A5 JP 2022544227A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- antibody
- cancer
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025051867A JP2025106332A (ja) | 2019-08-13 | 2025-03-26 | １９１ｐ４ｄ１２タンパク質に結合する抗体薬物コンジュゲート（ａｄｃ）による癌の治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962886270P | 2019-08-13 | 2019-08-13 | |
| US62/886,270 | 2019-08-13 | ||
| PCT/US2020/045567 WO2021030240A1 (en) | 2019-08-13 | 2020-08-10 | Treatment of cancers with antibody drug conjugates (adc) that bind to 191p4d12 proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025051867A Division JP2025106332A (ja) | 2019-08-13 | 2025-03-26 | １９１ｐ４ｄ１２タンパク質に結合する抗体薬物コンジュゲート（ａｄｃ）による癌の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544227A JP2022544227A (ja) | 2022-10-17 |
| JP2022544227A5 true JP2022544227A5 (cg-RX-API-DMAC7.html) | 2023-08-16 |
| JP7657774B2 JP7657774B2 (ja) | 2025-04-07 |
Family
ID=74569853
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022508480A Active JP7657774B2 (ja) | 2019-08-13 | 2020-08-10 | １９１ｐ４ｄ１２タンパク質に結合する抗体薬物コンジュゲート（ａｄｃ）による癌の治療方法 |
| JP2025051867A Withdrawn JP2025106332A (ja) | 2019-08-13 | 2025-03-26 | １９１ｐ４ｄ１２タンパク質に結合する抗体薬物コンジュゲート（ａｄｃ）による癌の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025051867A Withdrawn JP2025106332A (ja) | 2019-08-13 | 2025-03-26 | １９１ｐ４ｄ１２タンパク質に結合する抗体薬物コンジュゲート（ａｄｃ）による癌の治療方法 |
Country Status (13)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019392090A1 (en) | 2018-12-03 | 2021-06-17 | Agensys, Inc. | Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof |
| EP4143344A1 (en) * | 2020-04-27 | 2023-03-08 | Agendia N.V. | Treatment of her2 negative, mammaprint high risk 2 breast cancer |
| IL302006A (en) * | 2020-10-11 | 2023-06-01 | Agensys Inc | Methods for treating cancer with antibody-drug conjugates (ADC) that bind to proteins 191P4D12 |
| EP4301774A4 (en) * | 2021-03-03 | 2025-08-13 | Dragonfly Therapeutics Inc | METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS THAT BIND TO NKG2D, CD16, AND A TUMOR-ASSOCIATED ANTIGEN |
| WO2024012536A1 (zh) * | 2022-07-14 | 2024-01-18 | 百奥泰生物制药股份有限公司 | 抗Nectin-4抗体、其抗体药物偶联物及应用 |
| JP2026508244A (ja) | 2023-02-22 | 2026-03-10 | ナンジング リーズ バイオラブズ シーオー．， エルティーディー． | 抗Ｎｅｃｔｉｎ－４抗体及びそれを含む多重特異性抗体 |
| KR20250057677A (ko) * | 2023-10-19 | 2025-04-29 | (주)셀트리온 | 캄프토테신 유도체를 포함하는 항-Nectin-4 항체-약물 접합체 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX347954B (es) * | 2010-09-29 | 2017-05-19 | Agensys Inc | Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12. |
| WO2012068279A2 (en) * | 2010-11-16 | 2012-05-24 | InnerGeo LLC | System and method for extracting energy |
| JP2018521019A (ja) * | 2015-06-08 | 2018-08-02 | ジェネンテック， インコーポレイテッド | 抗ｏｘ４０抗体を使用して癌を治療する方法 |
| BR112019002405A2 (pt) * | 2016-08-26 | 2019-06-04 | Hydril Usa Distrib Llc | conjunto de transdutor para riser de perfuração offshore |
| AU2019392090A1 (en) * | 2018-12-03 | 2021-06-17 | Agensys, Inc. | Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof |
-
2020
- 2020-08-10 TW TW114105048A patent/TW202540197A/zh unknown
- 2020-08-10 US US17/634,026 patent/US20230001005A1/en active Pending
- 2020-08-10 CA CA3150274A patent/CA3150274A1/en active Pending
- 2020-08-10 MX MX2022001731A patent/MX2022001731A/es unknown
- 2020-08-10 TW TW109127017A patent/TWI873167B/zh active
- 2020-08-10 BR BR112022002391A patent/BR112022002391A2/pt unknown
- 2020-08-10 AU AU2020329761A patent/AU2020329761A1/en active Pending
- 2020-08-10 EP EP20853452.9A patent/EP4013795A4/en not_active Withdrawn
- 2020-08-10 WO PCT/US2020/045567 patent/WO2021030240A1/en not_active Ceased
- 2020-08-10 CN CN202080071695.6A patent/CN114901690A/zh active Pending
- 2020-08-10 PH PH1/2022/550318A patent/PH12022550318A1/en unknown
- 2020-08-10 JP JP2022508480A patent/JP7657774B2/ja active Active
- 2020-08-10 KR KR1020227007845A patent/KR20220054321A/ko active Pending
-
2022
- 2022-02-07 IL IL290391A patent/IL290391A/en unknown
-
2025
- 2025-03-26 JP JP2025051867A patent/JP2025106332A/ja not_active Withdrawn